Dasatinib Drugs Market

Dasatinib, sold under the brand name Sprycel, is a chemotherapy medication used to treat certain cases of chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL).

Dasatinib Drugs Market contains market size and forecasts of Dasatinib Drugs in global, including the following market information:

• Global Dasatinib Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Dasatinib Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
• Global top five Dasatinib Drugs companies in 2021 (%)

The global Dasatinib Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

20mg Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Dasatinib Drugs include Bristol-Myers Squibb and LUCIUS Pharma etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Dasatinib Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Dasatinib Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Dasatinib Drugs Market Segment Percentages, by Type, 2021 (%)

• 20mg
• 50mg
• 70mg

Global Dasatinib Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Dasatinib Drugs Market Segment Percentages, by Application, 2021 (%)

• CML
• ALL

Global Dasatinib Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Dasatinib Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Dasatinib Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Dasatinib Drugs revenues share in global market, 2021 (%)
• Key companies Dasatinib Drugs sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Dasatinib Drugs sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Bristol-Myers Squibb
• LUCIUS Pharma